|
EP3808729A1
|
|
Method for producing 1-palmitoyl-2-linoleoyl-3-acetyl glycerol
|
|
WO2020178803A1
|
|
Composition comprising monoacetyldiacylglycerol compound for treating fatty liver disease
|
|
WO2020144538A1
|
|
Compositions and methods for modulating an inflammatory response
|
|
KR20200107730A
|
|
A composition for treating fatty liver disease comprising monoacetyldiacylglycerol compound as an active ingredient
|
|
KR20200121669A
|
|
Composition for treating gout containing monoacetyldiacylglycerol compound and method for treating gout
|
|
KR20200121668A
|
|
Composition for treating diabetes containing monoacetyldiacylglycerol compound and method for treating diabetes
|
|
KR20200091980A
|
|
Method for producing polmacoxib
|
|
WO2020148562A1
|
|
Methods and compositions for treatment of cancer
|
|
WO2019106632A1
|
|
Compositions for prevention or treatment of acute radiation syndrome
|
|
KR20200045078A
|
|
Methods for the analysis of taurolidine, taurultam and taurinamide
|
|
KR20190123123A
|
|
Glycerol derivatives, method for preparing these and immunomodulating agent including the same as active ingredient
|
|
KR20190112492A
|
|
1,2-diacylglycerol compound, method for preparing the same and immunomodulating agent including the same as active ingredient
|
|
KR20190107522A
|
|
Diacylglycerol lactone compound, method for preparing the same and immunity enhancing agent including the same as active ingredient
|
|
KR20190088792A
|
|
Gadoteridol intermediate and method for preparing gadoteridol using the same
|
|
KR20190088793A
|
|
Manufacturing method of calcobutrol
|
|
KR20190073121A
|
|
Crystallizine Sapogrelate Hydrochloride and a method for forming the same
|
|
KR20190063536A
|
|
Composition for preventing or treating acute radiation syndrome comprising 1-palmitoyl-2-linoleoyl-3-acetylglycerol
|
|
KR20190025131A
|
|
Gadobutrol intermediate and method for preparing gadobutrol using the same
|
|
KR101859200B1
|
|
Pharmaceutical composition of monoacetyldiacylglycerol compound for oral administration and solid pharmaceutical preparation
|
|
WO2017082708A1
|
|
Method for treating paroxysmal nocturnal hemoglobinuria
|
